Created at Source Raw Value Validated value
Oct. 7, 2021, 9:30 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "This arm is a group of in Thai individuals who received 2 doses of CoronaVac vaccines. They were enrolled to recieve a booster dose (third dose vaccine) which is either Astrazeneca (AZ) full dose; AZ half dose; Pfizer (PF) full dose; PF half dose; Moderna (MO) full dose; MO half dose; and Sinopharm full dose at 3 or 6 months post second dose CoronaVac vaccination.;This arm is a group of in Thai individuals who received 2 doses of Astrazeneca (AZ) vaccines. They were enrolled to recieve a booster dose (third dose vaccine) which is either Pfizer (PF) full dose; PF half dose; Moderna (MO) full dose or MO half dose at 6 months post first dose AZ vaccination.;Active Comparator Drug;Active Comparator Drug;Booster with AZ; PF; MO; SP vaccine;Booster with PF; MO vaccine", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "full dose (third dose);individuals who received 2 doses of CoronaVac vaccines 3 or 6 months ago", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "half dose (third dose);individuals who received 2 doses of CoronaVac vaccines 3 or 6 months ago", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose (third dose);individuals who received 2 doses of CoronaVac vaccines 3 or 6 months ago", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "half dose (third dose);individuals who received 2 doses of CoronaVac vaccines 3 or 6 months ago", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose (third dose);individuals who received 2 doses of CoronaVac vaccines 3 or 6 months ago", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "half dose (third dose);individuals who received 2 doses of CoronaVac vaccines 3 or 6 months ago", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose (third dose);individuals who received 2 doses of CoronaVac vaccines 3 or 6 months ago", "treatment_id": 184, "treatment_name": "Bbibp-corv", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose (third dose);individuals who received 2 doses of ChAdOx1 nCoV-19 vaccines (at 6 months post first dose)", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "half dose (third dose);individuals who received 2 doses of ChAdOx1 nCoV-19 vaccines (at 6 months post first dose)", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "full dose (third dose);individuals who received 2 doses of ChAdOx1 nCoV-19 vaccines (at 6 months post first dose)", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "half dose (third dose);individuals who received 2 doses of ChAdOx1 nCoV-19 vaccines (at 6 months post first dose)", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]